Abstract:Background Epicardial (EAT) and pericoronary adipose tissue (PCAT) are known as risk predictors of subclinical atherosclerosis and coronary artery disease. We aimed to evaluate the association of EAT and PCAT volume and attenuation with the presence of high risk coronary plaque burden in patients with vs. without lipid lowering therapy. Methods In the present retrospective analysis a total of 321 patients undergoing coronary CTA at the XXX were included. EAT and PCAT were manually traced from CT imaging for assessment of fat volume and attenuation. According to the SCCT guidelines for the interpretation of coronary CTA, each coronary segment was evaluated for the presence of high risk plaque features (napkin ring sign, spotty calcification, positive remodeling, and low attenuation plaque). Results Overall data from 321 patients (mean age: 55.5±14.7 years, 62% male) and a total of 5778 coronary segments were included in our analysis. The cohorts consists of 116 patients without plaque and stenosis, 96 patients with plaque but no significant stenosis and 109 patients with obstructive coronary stenosis. Highest rates of the presence of coronary plaque were detected in proximal LAD (17.9%), followed by mid LAD (12.9%) and proximal RCA (10.8%). Coronary stenosis was also most common in proximal LAD (14.6%), followed by mid LAD (12.1%) and proximal RCA (11%). High risk plaque features were found in 401 segments and were most frequently located in the proximal LAD (21.4%). EAT volume increased with higher rates of stenosis and plaque (44.7±25.2ml vs. 68,2±28,5ml vs. 85.2±31.7ml, p<0.001). Prevalence of high risk plaque increased by higher EAT volume (OR [95% CI]: 3.17 [2.33–4.33], p<0.0001) and remains stable after upon adjustment for risk factors (2.32 [1.46–3.7], p<0.0001). EAT attenuation also significantly associated with the presence of high risk plaques with 0.68-folded risk in the unadjusted (0.68 [0.53–0.88], p=0.003), and 0.62-folded risk in the multivariate (MV) adjusted regression analysis (0.62 [0.45–0.85], p=0.003). However, for PCAT only its volume but not its attenuation was significantly associated with presence of high risk plaques in MV-adjusted regression analysis (PCAT volume: 2.25 [1.02–4.96], p=0.044; PCAT attenuation: 0.84 [0.63–1.12], p=0.24). Furthermore, patients receiving lipid-lowering therapy showed a significantly lower probability for high risk plaque detection (0.17 [0.14–0.21], p<0.0001). These findings remained stable after multivariate adjustment (0.27 [0.21–0.35], p<0.0001). Conclusion EAT volume and attenuation as well as PCAT volume associate with high risk plaques independent of traditional cardiovascular risk factors. In contrast, we found no significant association of PCAT attenuation with high risk coronary atherosclerosis. Our results encourage further research to evaluate the interplay of lipid-lowering therapy and EAT on plaque composition. Funding Acknowledgement Type of funding sources: None.

The interaction of lipomatous hypertrophy of the interatrial septum with pericardial adipose tissue biomarkers by computed tomography

Lipomatous hypertrophy of the interatrial septum: a distinct adipose tissue type in COPD?

Impact of Epicardial Adipose Tissue Volume on Hemodynamically Significant Coronary Artery Disease in Chinese Patients with Known or Suspected Coronary Artery Disease

[Volumetric Measurement of Pericardial and Intrathoracic Adipose Tissues Using Coronary Computed Tomography Angiography in Patients with Coronary Heart Disease].

The prognostic value of Epicardial and Pericoronary Adipose Tissue in Heart Failure with Preserved Ejection Fraction Using Coronary Computed Tomography Angiography

Epicardial fat density obtained with computed tomography imaging - more important than volume?

Epicardial and pericoronary fat volume and attenuation, lipid lowering therapy and coronary high risk coronary plaque burden

Association of pericardial adipose tissue with left ventricular structure and function: a region-specific effect?

Relationships of pericoronary and epicardial fat measurements in male and female patients with and without coronary artery disease

Echocardiographic Epicardial Adipose Tissue Thickness for Risk Stratification of Patients With Heart Failure

Epicardial Adipose Tissue Attenuation and Fat Attenuation Index: Phantom Study and In Vivo Measurements With Photon-Counting Detector CT

Importance of Multimodality Cardiac Imaging in the Diagnosis of Lipomatous Hypertrophy of the Interatrial Septum—A View beyond Standard Situations

Abstract 19411: Inter-Atrial Regional Adipose Burden in Relation To Metabolic Abnormalities as a Novel Clinical Marker for Left Atrial Remodeling in Preserved Ejection Fraction Heart Failure

Increased Epicardial Fat Tissue is Predictor for Patients with Ischemia and No Obstructive Coronary Artery Disease

Association of Pericardial Adipose Tissue Measured by Dual Source Computed Tomography with Severity of Coronary Atherosclerosis

Prognostic implications of epicardial fat volume quantification in acute pericarditis

A preliminary coronary computed tomography angiography-based study of perivascular fat attenuation index: relation with epicardial adipose tissue and its distribution over the entire coronary vasculature

Epicardial and Pericoronary Adipose Tissue, Coronary Inflammation, and Acute Coronary Syndromes

The Association of Pericardial Adipose Tissue with Coronary Artery Disease and Metabolic Risk Factors in Non-Overweight Patients

Epicardial Adipose Tissue Characteristics and CT High-Risk Plaque Features: Correlation with Coronary Thin-Cap Fibroatheroma Determined by Intravascular Ultrasound

Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies